← All trials
NCT02302469
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2009
- Primary completion
- Mar 1, 2017
- Completion date
- Apr 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 17
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of LilleLead sponsor
- CelgeneCollaborator
- Centre Hospitalier de LensOverall official - principal investigator
- University of NantesOverall official - principal investigator
- University of LyonOverall official - principal investigator
- University Clermont AuvergneOverall official - principal investigator
- University of LilleStudy director
- University of ParisOverall official - principal investigator
- CH BAYONNEOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.